News
Latest news
More-
ZAS Netwerk partners with Aiosyn to evaluate AI-powered mitosis detection in clinical settings
-
Explore the clinical performance insights of Aiosyn Mitosis Breast at USCAP 2024
-
Aiosyn and Physiogenex partner to enhance kidney disease drug development
-
Aiosyn launches Kidney Image Analysis Services through its NephroPath platform to accelerate drug development studies
-
Aiosyn partners with Paige to enhance the accessibility of AI-powered automated quality control in pathology laboratories worldwide
Publications
More-
Convolutional Neural Networks for the Evaluation of Chronic and Inflammatory Lesions in Kidney Transplant Biopsies
-
Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge
-
Deep learning in histopathology: the path to the clinic
-
Deep learning enables fully automated mitotic density assessment in breast cancer histopathology
-
Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists
Blog
More-
The benefits of AI implementation in mitotic figure counting
-
Diana Rosentul explains the complexities of regulatory compliance for integrating AI-based solutions in the healthcare industry
-
Cristina González Gonzalo discusses her journey with the clinical validation of Aiosyn Mitosis Breast
-
Time to go digital? Navigating the pathology transition from microscopes to whole slide images
-
Prepare for the future: AI is changing the landscape of pathology